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Abstract
Recently an association was demonstrated between the single nucleotide polymorphism (SNP), rs9939609, within the FTO
locus and obesity as a consequence of a genome wide association (GWA) study of type 2 diabetes in adults. We examined
the effects of two perfect surrogates for this SNP plus 11 other SNPs at this locus with respect to our childhood obesity
cohort, consisting of both Caucasians and African Americans (AA). Utilizing data from our ongoing GWA study in our cohort
of 418 Caucasian obese children (BMI$95th percentile), 2,270 Caucasian controls (BMI,95th percentile), 578 AA obese
children and 1,424 AA controls, we investigated the association of the previously reported variation at the FTO locus with
the childhood form of this disease in both ethnicities. The minor allele frequencies (MAF) of rs8050136 and rs3751812
(perfect surrogates for rs9939609 i.e. both r
2=1) in the Caucasian cases were 0.448 and 0.443 respectively while they were
0.391 and 0.386 in Caucasian controls respectively, yielding for both an odds ratio (OR) of 1.27 (95% CI 1.08–1.47; P=0.0022).
Furthermore, the MAFs of rs8050136 and rs3751812 in the AA cases were 0.449 and 0.115 respectively while they were 0.436
and 0.090 in AA controls respectively, yielding an OR of 1.05 (95% CI 0.91–1.21; P=0.49) and of 1.31 (95% CI 1.050–1.643;
P=0.017) respectively. Investigating all 13 SNPs present on the Illumina HumanHap550 BeadChip in this region of linkage
disequilibrium, rs3751812 was the only SNP conferring significant risk in AA. We have therefore replicated and refined the
association in an AA cohort and distilled a tag-SNP, rs3751812, which captures the ancestral origin of the actual mutation. As
such, variants in the FTO gene confer a similar magnitude of risk of obesity to children as to their adult counterparts and
appear to have a global impact.
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Introduction
Obesity is a major health problem in modern societies.
Approximately 127 million adults in the U.S. are overweight
(BMI.25), 60 million are obese (BMI.30), and 9 million are
severely obese (BMI.40). Obesity also shows increasing preva-
lence in children. Childhood obesity is considered to have reached
epidemic levels in developed countries. In the 10 years between
the National Health and Nutrition Examination Survey
(NHANES) II (1976–1980) and NHANES III (1988–1991), the
prevalence of overweight children in the USA had increased by
approximately 40%[1].
Approximately 70% of obese adolescents grow up to become
obese adults[2,3,4]. The main direct adverse effects of childhood
obesity include orthopedic complications, sleep apnea, and
psychosocial disorders[5,6]. Obesity and its associated phenotype,
insulin resistance[7,8], is also considered a contributor to the
major causes of death in the United States and is an important risk
factor for type 2 diabetes (T2D), cardiovascular disease, hyper-
tension and other chronic diseases[9]. Obesity present in
adolescence has been shown to be associated with increased
overall mortality in adults[10].
The Center for Disease Control and Prevention has defined
overweight as BMI$95
th percentile for each age group whereas
European researchers use that same definition to classify
obesity[11]. The Institute of Medicine also specifically uses the
term ‘‘obesity’’ to characterize BMI$95
th percentile in children
and adolescents[12], and these statistical percentile definitions are
now general guidelines for clinicians and others[13].
Whereas the rising prevalence of obesity can be partly explained
by environmental changes over the last 30 years, in particular the
unlimited supply of convenient, highly calorific foods together with
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component to the risk of obesity[14,15]. The familial occurrences
of obesity have long been noted. For example, the concordance for
fat mass among monozygotic twins is reported to be 70–90%,
higher than the 35–45% concordance in dizygotic twins[16,17],
suggesting the heritability of BMI ranges from 30 to
70%[18,19,20,21]. The genetic impact on obesity is also reflected
in prevalence differences between racial groups, from 5% or less in
Caucasian and Asian populations to 50% or more among Pima
Indians[22] and South Sea Island populations[23].
Recently, a number of studies have reported remarkably strong,
replicable associations with complex disease, including the
complement factor H (CFH) gene in age-related macular
degeneration[24,25,26] and the transcription factor 7-like-2
(TCF7L2) gene in type 2 diabetes[27,28,29].
Although two genes for obesity have already been reported from
the outcome of genome wide association (GWA) studies, the role of
INSIG2 gene[30] has proven to be controversial due to three
subsequent technical comments to Science[31,32,33] that disagreed
with this observation, while the identification of the second gene,
FTO [NM_001080432][34], was made indirectly as a consequence
of T2D GWA studies[35,36]. This gene variant turned out to be
operating through insulin resistance and was found to be
associated with adult BMI, and subsequently pediatric BMI, in
the original study. In an independent study of the genetics of BMI
that came out around the same time, similar conclusions were
drawn[37].
Although these FTO findings are compelling, there are
continuing concerns regarding the performance of association
studies in complex traits. As such, independent replication efforts
are now considered mandatory[38]. With the many errors and
biases that can blight any individual study, replication by others
can ensure that the original findings are robust and can also
provide a more accurate estimate of the likely effect size[39,40].
In this study we demonstrate that two SNPs, rs8050136 and
rs3751812, in the FTO gene confer a similar magnitude of risk for
obesity in our pediatric cohort as previously reported in both
adults and children with the same phenotype, further supporting
the notion that the FTO pathway is causally linked to the disorder
in children. In addition, we have replicated and refined the
association in an African American (AA) cohort and distilled a tag-
SNP, namely rs3751812, to capture the ancestral origin of the
underlying mutational event.
Results
Association between rs8050136 and rs3751812 and
childhood obesity risk in Caucasians
Using the allelic chi-squared association test, we observed
significant association between rs8050136 and rs3751812 and risk
for childhood obesity. The minor allele frequencies (MAFs) of
these two SNPs in the Caucasian cases were 0.448 and 0.443,
respectively, whereas the MAFs were 0.391 and 0.386, respec-
tively, in the Caucasian controls, yielding for both an odds ratio
(OR) of 1.27 (95% CI 1.08–1.47; P=0.0022) (Table 1a). This OR
is very much in line with that reported previously in the adult case-
control cohort (OR=1.2)[34].
We also analyzed 11 additional SNPs on the Illumina 550K
BeadChip in the region of LD harboring the association signal.
Table 1a shows that five other SNPs that are in strong, but not in
perfect LD with rs9939609 were also nominally associated with
childhood obesity. Further analysis on haplotypes suggests that the
major alleles of these SNPs are more likely to be on the same
haplotype as the minor alleles of rs8050136 and rs3751812 (Table
S1). The corresponding analysis of the entire cohort as a
quantitative trait with these SNPs is shown in Table S2.
Association between rs8050136 and rs3751812 and
childhood obesity risk in African Americans
We also analyzed rs8050136 and rs3751812 in our 578 AA
obese children and 1,424 AA controls (BMI,95th percentile). The
MAFs in the AA cases were 0.449 and 0.115 respectively, whereas
the MAFs were 0.436 and 0.090, respectively, in the AA controls,
yielding an OR of 1.05 (95% CI 0.91–1.21; P=0.49) and of 1.31
(95% CI 1.050–1.643; P=0.017) (Table 1b). It is worth noting that
rs8050136 shows strong LD with rs9939609 in the YRI sample
(r
2=0.819), whereas rs3751812 is only in weak LD (r
2=0.058).
In addition, we analyzed the other 11 SNPs on the Illumina
550K BeadChip in the region of LD harboring the signal as seen
in Caucasian samples. None of these additional SNPs showed
nominally significant association to the phenotype (Table 1b). The
corresponding analysis of the entire cohort as a quantitative trait
with these SNPs is shown in Table S2.
These results demonstrate the impact of variation at this locus in
AA and how we have refined the signal to rs3751812, such that it
is closer to the causative underlying mutation (Figure 1). This is as
a consequence of LD structural differences between African and
Caucasian ancestries, as seen in our cohort (Figure S1) and in the
HapMap (Figure S2).
Discussion
From an interim analysis of our ongoing GWA study of
childhood obesity, we have investigated variation in the FTO locus
previously reported to be associated with both the adult and
pediatric forms of the disease[34]. Consequently, we have
replicated association of this gene with obesity by further
demonstrating its effect in the childhood form of the disorder.
More specifically, the common non-coding variants, rs8050136
and rs3751812 (perfect surrogates for the previously reported
rs9939609 i.e. both r
2=1 in Caucasians), were shown to confer
risk for the disorder with comparable odds ratios to that previously
observed.
Although the size of the cohort in the original genome wide
association study was larger[34], the amount of testing in our
cohort was restricted to a focused effort of specifically investigating
if SNPs in the FTO gene also yield association in the same
direction as previously reported. Our cohort is therefore
sufficiently powered to ask this straight-forward validation
question.
As the association we observe is indeed of a very similar
magnitude to that of the original reports[34,37], this independent
replication confirms FTO as a genuine childhood obesity
susceptibility gene. As such, the ‘‘winner’s curse’’ that is often
seen for other complex trait susceptibility genes[41] is not
observed in this instance.
What is worth particular note is that the association observed in
children is almost identical to that of adults. With the gene-
environment interaction[42] models in mind, we have been
motivated to look at the genetics of childhood disease in order to
more readily distill the genetic component in these phenotypes due
to the fact that environmental exposure and impact has been for a
relatively short period of their lifetime. However, with the
magnitude of the association being so comparable between
children and adults, this particular research outcome suggests that
the environmental interaction with this variant over time is
negligible and in fact this variant may be primarily associated with
early onset obesity.
Key SNP Assesses Obesity & FTO
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globally identify and understand the genetic and environmental
factors associated with estimates of obesity, as variants found in
populations of both African and Caucasian ancestry may represent
more universally important genes and pathways for subsequent
diagnosis, prevention and treatment of obesity and its complica-
tions. As such, a cohort of African ancestry in many instances can
aid in refining the anticipated association(s) made in our GWA
approach. Therefore, analysis of key markers specifically in an AA
cohort is part of our study design in order to help investigate if any
of the association signals can be refined and localized further due
to lower LD in this ethnicity. Such an instance occurred for FTO
in our AA cohort of obese children and controls. Self-reported
African ethnicity proved to be accurate, as the resulting genomic
inflation factor was only 1.06. SNP rs3751812 yielded association,
whereas the other SNP rs8050136, which showed evidence of
association in Caucasians, was not associated in the AA cohort.
In addition, the other 11 SNPs at the locus failed to show any
evidence of association in the AA cohort. These results
demonstrate the impact of variation at this locus in AA and how
we have refined the signal to rs3751812, which it is potentially
closer to the causative underlying mutational event. Figure 1
demonstrates this point, where in Caucasians there are multiple
SNPs in LD showing nominally significant association (Figure 1a)
while in the AA, all but one falls away (Figure 1b). Interestingly,
the associated rs3751812 is not in strong LD with the originally
reported rs9939609 in African ancestry populations (r
2=0.058)
while rs8050136, which failed to show association in AA, is in
strong LD (r
2=0.819). However, the minor allele frequency of
rs3751812 differs substantially between the two ethnicities,
Table 1. Childhood obesity case-control association study results for FTO region markers perfectly correlated with rs9939609 in
Caucasians (bold) plus all other markers present on the BeadChip in the corresponding HapMap CEU region of LD in our (a)
Caucasian and (b) African American cohorts respectively.
(a) Caucasians
Chr SNP
r
2 to
rs9939609
B35
location
Minor
Allele
Major
Allele
Aff MAF
(n=418)
Ctrl MAF
(n=2270) OR 95% CI P-value
16 rs9930333 0.843 52357478 T G 0.476 0.425 1.228 1.058–1.427 0.0070
16 rs10852521 0.584 52362466 T C 0.422 0.484 0.779 0.670–0.906 0.0011
16 rs16945088 0.099 52370025 G A 0.094 0.090 1.056 0.818–1.365 0.68
16 rs8050136 1 52373776 A C 0.448 0.391 1.266 1.088–1.471 0.0022
16 rs3751812 1 52375961 T G 0.443 0.386 1.267 1.089–1.473 0.0022
16 rs12597786 0.014 52378808 T C 0.026 0.020 1.320 0.815–2.138 0.26
16 rs9931164 0.022 52382739 G A 0.020 0.019 1.024 0.597–1.756 0.93
16 rs9941349 0.9 52382989 T C 0.462 0.407 1.254 1.080–1.457 0.0030
16 rs7199182 - 52383621 G A - - - - -
16 rs7190492 0.328 52386253 A G 0.296 0.354 0.767 0.651–0.903 0.0014
16 rs8044769 0.62 52396636 T C 0.414 0.483 0.758 0.652–0.881 0.00031
16 rs6499646 0.101 52401034 C T 0.103 0.092 1.141 0.890–1.462 0.30
16 rs1421090 0.026 52407671 C T 0.273 0.260 1.073 0.907–1.270 0.41
(b) African Americans
Chr SNP
r
2 to
rs9939609
B35
location
Minor
Allele
Major
Allele
Aff MAF
(n=578)
Ctrl MAF
(n=1424) OR 95% CI P-value
16 rs9930333 0.388 52357478 G T 0.474 0.457 1.070 0.932–1.229 0.33
16 rs10852521 0.021 52362466 T C 0.251 0.267 0.922 0.787–1.079 0.31
16 rs16945088 0.619 52370025 G A 0.310 0.299 1.054 0.907–1.223 0.49
16 rs8050136 0.819 52373776 A C 0.449 0.437 1.051 0.914–1.207 0.49
16 rs3751812 0.058 52375961 T G 0.115 0.090 1.313 1.050–1.643 0.017
16 rs12597786 0.018 52378808 T C 0.022 0.024 0.902 0.567–1.434 0.66
16 rs9931164 0.058 52382739 G A 0.045 0.049 0.902 0.649–1.253 0.54
16 rs9941349 0.02 52382989 T C 0.187 0.170 1.125 0.941–1.345 0.20
16 rs7199182 0.486 52383621 G A 0.296 0.308 0.945 0.813–1.099 0.46
16 rs7190492 0.044 52386253 A G 0.204 0.198 1.037 0.872–1.233 0.68
16 rs8044769 0.039 52396636 T C 0.233 0.234 0.995 0.846–1.171 0.95
16 rs6499646 0.004 52401034 T C 0.432 0.399 1.148 0.998–1.320 0.053
16 rs1421090 0.041 52407671 C T 0.294 0.291 1.014 0.872–1.180 0.85
Minor allele frequencies (MAF), allelic test P-values, and odds ratios (OR) with 95% confidence intervals (CI) are shown for each SNP. rs7199182 has a MAF,1% in
Caucasians so was not analyzed in that ethnicity. The ORs shown are for the minor allele. P-values are two-sided in each instance. r
2 values to rs9939609 derived from (a)
CEU and (b) YRI HapMap samples are also shown.
doi:10.1371/journal.pone.0001746.t001
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differently by this SNP in these populations.
Importantly, if investigators only analyze rs9939609 in their
cohorts of African ancestry, they would miss the association of
obesity with this locus, as has already been reported[43]. As such
investigators should test both rs3751812 and rs9939609 in their
obese cohorts around the world in order to thoroughly assess the
influence of this locus on the phenotype globally. For example, Li
et al[44] showed no association of rs8050136 and rs9939609 with
obesity in a Chinese population so testing rs3751812 in these
populations needs to be addressed before strong conclusions can
be drawn on the role of variation in FTO in obesity predisposition
in this ethnicity.
This is similar to what occurred in the case of association of
variants in the TCF7L2 gene with T2D. In Caucasians, one
microsatellite and five SNPs were reported to capture the
association[27] while all but one failed to show association in a
T2D cohort from West Africa, namely rs7903146[45], thus also
getting closer to the underlying variant.
Our results lend further support for the role of the FTO gene in
obesity, suggesting that interventions at the FTO pathway level
may be of value in patients who suffer from this disease. The FTO
gene encodes the fat mass and obesity associated protein, Fatso and
has been recently shown to be a 2-Oxoglutarate–Dependent
Nucleic Acid Demethylase[46]. The variants that we observe
association to may directly dictate splicing or some other
regulatory mechanism but more likely are in LD with the
causative variant(s).
Once our GWA study is complete, we will have the opportunity
to look for other variants in the genome that are associated with
childhood obesity, as a consequence of our use of a high resolution
BeadChip. In addition, we will explore the FTO gene further to
elucidate other potential variants that may confer genetic
susceptibility to this disorder in our cohort.
Materials and Methods
Study Subjects
All subjects were consecutively recruited from the Greater
Philadelphia area from 2006 to 2007 at the Children’s Hospital of
Philadelphia. Our study consisted of 418 Caucasian obese children
(BMI$95th percentile), 2,270 Caucasian controls (BMI,95th
percentile), 578 AA obese children and 1,424 AA controls
(BMI,95th percentile). All of these participants had their blood
drawn in to an 8 ml EDTA blood collection tube and were
subsequently DNA extracted for genotyping. BMI$95th percen-
tile was defined using the Center for Disease control (CDC) z-
score=1.645 (http://www.cdc.gov/nchs/about/major/nhanes/
growthcharts/datafiles.htm). All subjects were biologically unre-
lated and were aged between 2 and 18 years old. All subjects were
between 23 and +3 standard deviations of CDC corrected BMI
i.e. outliers were excluded to avoid the consequences of potential
measurement error or Mendelian causes of extreme obesity. This
study was approved by the Institutional Review Board of the
Children’s Hospital of Philadelphia. Parental informed consent
was given for each study participant for both the blood collection
and subsequent genotyping.
Genotyping
We performed high throughput genome-wide SNP genotyping
using the Illumina Infinium
TM II HumanHap550 BeadChip
technology[47,48] in the same manner as our center has reported
previously[49]. The resources available for this project included
the Illumina technology platform itself plus nine Tecan pipetting
robotic systems, eight scanners, a laboratory information man-
agement system (LIMS) and automated allele-calling software.
The workflow was robotic-based for automatic sample processing
and included algorithms for quality control of genotypes. The
facility infrastructure had sufficient computational power and
Figure 1. Linkage disequilibrium (r
2) between SNPs at the FTO
locus in (a) Caucasians and (b) African Americans: Plotted are
2log10(P-value) of allelic chi-squared tests. The strength of
linkage disequilibrium (r
2) between SNPs is represented both numer-
ically and by the depth of shading
doi:10.1371/journal.pone.0001746.g001
Key SNP Assesses Obesity & FTO
PLoS ONE | www.plosone.org 4 March 2008 | Volume 3 | Issue 3 | e1746servers for data processing and storing, including a series of
computers that were integrated (warehouse setting) to perform
continuous datamining of all gathered and generated datasets.
Analysis
SNP rs9939609 was not included on the Illumina 550K
BeadChip. However, we searched the HapMap database, and
found that two SNPs, which are present on our 550K BeadChip,
rs8050136 and rs3751812, are in complete LD with rs9939609
(both r
2=1) in the CEU sample. Therefore, we queried the data
with a test for these two perfectly correlated SNPs to investigate if
they are associated with obesity in our pediatric cohort. In
addition, we queried data for 11 additional SNPs that are in the
same region of LD as rs8050136 and rs3751812 in the Caucasian
samples. All statistical analyses were carried out using the software
package plink (http://pngu.mgh.harvard.edu/,purcell/plink/
index.shtml)[50]. For the case-control study, the single marker
association analysis for the genome-wide data was carried out
using the 1-df allelic chi-squared test. Odds ratios and the
corresponding 95% confidence intervals were calculated for each
SNP. All 13 FTO SNPs were in Hardy-Weinberg equilibrium in
both the cases and controls.
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